Clara Brando

Clara Brando has significant work experience in the biotechnology and pharmaceutical industry spanning over 30 years. Clara is currently working as the Director of Bioanalytical at Nektar Therapeutics since January 2023. Prior to that, they held the role of Associate Director at WuxiAppTec from March 2022 to January 2023. Clara also served as an Assistant Director at WuXi AppTec from April 2021 to January 2023. Clara worked as a Principal Scientist at Alliance Pharma from July 2020 to March 2021 and as a Scientific Director at Eurofins from July 2018 to June 2020. Clara's employment history also includes roles such as Principal Investigator at Bioanalytical Service Covance from January 2015 to June 2018, Assistant Research Investigator at Quintiles from August 2013 to December 2014, and Malaria Biologist at WRAIR from June 2011 to February 2013. Clara held various positions at WRAIR, including Senior Immunologist/Malaria Biologist and Mentor, from January 2002 to June 2011. Clara started their career as a Scientist at The Wistar Institute from August 1998 to January 2002 and as a Research Assistant Professor at Temple University from July 1994 to June 1998. At Temple University, they also served as a Post Doctoral Fellow at the Laboratory of Immunology at NIHID - NIH, Bethesda-MD from May 1990 to May 1994. Clara's experience includes conducting research, developing and validating analytical methods, supervising teams, and coordinating studies among researchers. Clara has a strong background in immunogenicity assessment and has worked on projects related to cell therapy for cancer and autoimmunity.

Clara Brando obtained a Master's Degree in Pharmaceutical Chemistry from the University of Torino in 1981. Subsequently, they pursued a PhD in Immunology at Immunology University of Torino, completing it in 1990.